Good points and I agree blafarm. Like most of us I am not an experienced OTC investor but completely believe in the science. In saying that, the OTC almost seems to be a different sport (hard to even compare Division II college team to MLB) in that I can’t recall the times over the past year that CytoDyn PR’d what seemed to be great news and ended in the red. I get the massive float, ugly balance sheet, manipulating traders, zero institutional investors, etc. compared to their peers that we continually see jump 30-200% on similar news.....but I’m still baffled that we are sub-$1 at this point. Sure some will claim NP has no credibility, missed timelines, no revenue, etc.....but the massive revenue potential of the promising indications puts any BP in the crosshairs to earn what I would think was a little respect. I haven’t researched, but before the massive market sell off, I’d bet their was Phase 1 pre-revenue biotechs trading on the bigger exchanges at 10x valuations of CYDY with less than 10% of the US only HIV market potential.

IMO our time will come, it’s more a matter of when and how much....and as you noted there are multiple things that could ignite that spark in the next couple of weeks. I doubt they will all come at once, but they all look very promising, so shorters keep shorting and let’s play ball!

Best of luck and hope everyone stays safe this weekend!